文献速递衰弱、肌少症与跌倒

血清肌酐与胱抑素C相关指数诊断肌少症的诊断准确性:系统综述与荟萃分析

Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis.
PubMed 文献 · Age Ageing · 2024-01-01

该系统综述与荟萃分析纳入16项研究共5566名参与者,评估基于血清肌酐和胱抑素C的指数对肌少症的诊断准确性。Cr/CysC比值与Cr×eGFRcys指数研究最多且性能相当,可能作为肌少症的替代标志物,但仍需进一步验证。

要点

  • Cr/CysC比值与Cr×eGFRcys指数是研究最多的指标,诊断性能相当。
  • 纳入研究均存在中至高度偏倚风险,结论需进一步验证。

核心结论

  • 基于血清Cr和CysC的指数对肌少症具有中等诊断准确性,最常研究的Cr/CysC比值和Cr×eGFRcys指数性能相当,可能作为肌少症的替代标志物,但需进一步验证。

研究设计与样本

  • 系统检索MEDLINE、EMBASE、SCIE和SCOPUS从建库至2023年4月2日的文献,最终纳入16项研究共5566名参与者(平均年龄范围51.0-78.4岁,男性占50.2%),采用QUADAS-2工具评估方法学质量,并使用双变量随机效应模型汇总敏感度、特异度和SROC-AUC。

主要发现

  • 肌少症患病率范围为7.8%至69.5%,所有纳入研究均存在中至高度偏倚风险。
  • Cr/CysC比值是研究最广泛的指数,其次是Cr×eGFRcys指数,两者在筛查肌少症方面性能满意且相当。

关键数值与推荐

  • 肌少症患病率范围7.8%至69.5%,平均年龄范围51.0-78.4岁,男性占50.2%。

临床怎么用

  • 基于Cr和CysC的指数(尤其是Cr/CysC比值和Cr×eGFRcys指数)可作为肌少症筛查的辅助工具,但因其中等诊断准确性,不能替代综合评估,结果需结合临床。

局限性

  • 所有纳入研究均存在中至高度偏倚风险,肌少症患病率变异大(7.8%-69.5%),结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sarcopenia is an important prognostic factor, but its optimal screening methods remain challenging. Several new indices developed based on serum creatinine (Cr) and cystatin C (CysC) have been proposed to be diagnostic biomarkers for sarcopenia screening. OBJECTIVE: This review aimed to evaluate the diagnostic accuracy of serum Cr- and CysC-based indices for sarcopenia diagnosis. METHODS: We systematically searched MEDLINE, EMBASE, SCIE and SCOPUS from inception to 2 April 2023. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. A bivariate random-effects model was used to synthesise the pooled sensitivity, specificity and area under the curves of the summary receiver operating characteristic (SROC-AUC). RESULTS: We retrieved 936 publications and included 16 studies with 5,566 participants (mean age ranged: 51.0-78.4 years, 50.2% men). The prevalence of sarcopenia ranged from 7.8 to 69.5%. All included studies presented a moderate to high risk of bias. The serum Cr- and CysC-based indices showed moderate diagnostic accuracy for sarcopenia (pooled sensitivity: 0.67, 95% CI 0.57-0.75; pooled specificity: 076, 95% CI 0.67-0.83; pooled SROC-AUC: 0.78, 95% CI 0.74-0.81). The Cr/CysC ratio is the most widely studied index, followed by the Cr × eGFRcys index. Overall, both indicators had satisfactory and comparable performance in screening sarcopenia. CONCLUSION: Serum Cr- and CysC-based indices showed moderate diagnostic accuracy for sarcopenia. The most studied indices-the Cr/CysC ratio and Cr × eGFRcys index-had comparable diagnostic accuracy for evaluating sarcopenia and may serve as surrogate markers for sarcopenia. However, further validation is required to verify these findings.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Lin T, Jiang T, Huang X, et al. Diagnostic test accuracy of serum creatinine and cystatin C-based index for sarcopenia: a systematic review and meta-analysis. Age Ageing. 2024. PMID: 38251741. doi:10.1093/ageing/afad252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。